Cardiomyopathy Trial, Recruiting (NCT06742008)

Cardiomyopathy Trial, Recruiting NCT06742008 Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06742008 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with VMC (confirm with trial site for full diagnosis details)
Your symptoms started no more than 30 days ago
You are between 18 and 75 years old
You (or your legal guardian) are willing to be fully informed about the study, join voluntarily, and sign a consent form

Who may not be able to join:

You have a serious infection that is not getting better despite treatment
You have active, uncontrolled bleeding at the time of joining the study
You have a systemic autoimmune disease (such as lupus) or a diagnosed immune deficiency condition
You are currently pregnant or breastfeeding
You have another serious illness, such as cancer, that means your life expectancy is less than 3 months
You are unlikely to be able to follow through with all the requirements of the study from start to finish
You have certain other conditions — such as severe sensitivity reactions, cognitive difficulties, mental health conditions, or substance use issues — that the study doctor feels could put you at greater risk or affect the study results (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86-13886121012

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06742008

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 86-13886121012

More information: https://clinicaltrials.gov/study/NCT06742008

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with VMC (confirm with trial site for full diagnosis details)
Your symptoms started no more than 30 days ago
You are between 18 and 75 years old
You (or your legal guardian) are willing to be fully informed about the study, join voluntarily, and sign a consent form

Who may not be able to join:

You have a serious infection that is not getting better despite treatment
You have active, uncontrolled bleeding at the time of joining the study
You have a systemic autoimmune disease (such as lupus) or a diagnosed immune deficiency condition
You are currently pregnant or breastfeeding
You have another serious illness, such as cancer, that means your life expectancy is less than 3 months
You are unlikely to be able to follow through with all the requirements of the study from start to finish
You have certain other conditions — such as severe sensitivity reactions, cognitive difficulties, mental health conditions, or substance use issues — that the study doctor feels could put you at greater risk or affect the study results (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Registry

ClinicalTrials.gov

Start date

17 December 2024

Est. completion

30 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of evolution to DCM in patients positive for anti-β1AR antibodies and anti-L-CaC antibodies

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov